Physician profile
Muhammad Ayub
NPI 1568814051
$70,899.37
in general payments reported to CMS, 2019-2025
17 companies · $6,973 in 2025
The $6,973 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $30K · 2023: $23K · 2024: $10K · 2025: $6,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $17K · Travel and Lodging: $16K · Food and Beverage: $6,807 · Education: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $17,207.84 |
| Travel and Lodging | $15,520.89 |
| Food and Beverage | $6,807.01 |
| Education | $973.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,983.89 | 2022-2025 | Micra, Affera Mapping System, Arctic Front Advance |
| Abbott Laboratories | $17,399.96 | 2021-2025 | Ensite Precision, Aveir, Assurity |
| Biotronik INC. | $12,290.48 | 2022-2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $9,712.47 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Philips North America LLC | $5,177.61 | 2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (5028) Igt Devices Systems Undivided |
| Biosense Webster, INC. | $720.24 | 2022-2024 | Carto 3, Qdot Micro Catheter, Na |
| Atricure, INC. | $257.58 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.16 | 2024 | Lifevest |
| Aimmune Therapeutics, INC. | $61.51 | 2025 | Vowst |
| Impulse Dynamics (USA) INC. | $39.19 | 2023 | Optimizer |
| Cardiva Medical, INC. | $35.65 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novartis Pharmaceuticals Corporation | $31.98 | 2025 | |
| Abiomed | $26.49 | 2025 | |
| Alnylam Pharmaceuticals INC. | $19.45 | 2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $18.08 | 2025 | Camzyos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $14.56 | 2021 | |
| Pfizer INC. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ayub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.